Work is underway in South Africa to amend the country’s national guidelines for drug-resistant TB to provide a shorter, six-month, all-oral regimen as a new standard of care treatment.

A study, published in The Lancet Infectious Diseases, compared outcomes up to 24 months after treatment initiation for patients with rifampicin-resistant TB in South Africa treated with a short, all-oral bedaquiline-containing regimen, or a short, injectable-containing regimen.

The World Health Organization (WHO) convened a scoping consultation on severe bacterial infections (SBIs) in advanced HIV disease (AHD), consulting with academics, program managers and civil society representatives.

The Communities Delegation to the UNITAID Board represents people living with and affected by HIV, TB and malaria and those co-infected with HIV and HCV, at the UNITAID Board and Committee level. The Communities Delegation is currently recruiting new members for the period 2022-2025. Interested individuals are invited to express their interest by 15 July 2022.

Jun 21, 2022: Researchers have identified how the bacterium that causes tuberculosis (TB) can evolve rapidly in response to new environments, says a study published today in eLife.

On 27 June 2022, the Global TB Caucus will host an online regional (Europe and Central Asia) forum: TB and migration. The forum will discuss the effects migration has on TB, in light of the recent events in Ukraine that have caused a spike in migration with an estimated five million people internally or externally displaced.

The Global TB Caucus releases an analysis examining the region’s laws on public health, health systems, labor, TB, and other infectious diseases.

The Global TB Caucus released a three-part video series: shorter-form primers that can easily inform people on key topics in the discussion surrounding TB.

A new animal study found mice infected with Mycobacterium tuberculosis and SARS-CoV-2 had an interesting synergism, according to a poster presented at ASM Microbe 2022 (abstract 3696), in Washington, D.C.

Seven out of 10 pregnant women were cured of their multidrug-resistant tuberculosis and delivered healthy babies after taking a medication that had previously been considered unsafe in pregnancy, a new Curtin and Telethon Kids Institute study has found.